The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · IEX Real-Time Price · USD
1.580
-0.260 (-14.13%)
At close: Mar 28, 2024, 4:00 PM
1.570
-0.010 (-0.63%)
After-hours: Mar 28, 2024, 6:50 PM EDT
The Oncology Institute Market Cap
The Oncology Institute has a market cap or net worth of $124.64 million as of March 28, 2024. Its market cap has increased by 149.77% in one year.
Market Cap
124.64M
Enterprise Value
161.46M
1-Year Change
149.77%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since March 11, 2020, The Oncology Institute's market cap has decreased from $293.20M to $124.64M, a decrease of -57.49%. That is a compound annual growth rate of -19.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 135.70M | 8.91% |
Mar 26, 2024 | 124.60M | 8.35% |
Mar 25, 2024 | 115.00M | 13.86% |
Mar 22, 2024 | 101.00M | 0.70% |
Mar 21, 2024 | 100.30M | -3.19% |
Mar 20, 2024 | 103.60M | -5.04% |
Mar 19, 2024 | 109.10M | -8.70% |
Mar 18, 2024 | 119.50M | -3.55% |
Mar 15, 2024 | 123.90M | -10.61% |
Mar 14, 2024 | 138.60M | 5.56% |
Mar 13, 2024 | 131.30M | 0.61% |
Mar 12, 2024 | 130.50M | 7.23% |
Mar 11, 2024 | 121.70M | -1.78% |
Mar 8, 2024 | 123.90M | -1.74% |
Mar 7, 2024 | 126.10M | 4.91% |
Mar 6, 2024 | 120.20M | -1.23% |
Mar 5, 2024 | 121.70M | -1.78% |
Mar 4, 2024 | 123.90M | -1.74% |
Mar 1, 2024 | 126.10M | -9.02% |
Feb 29, 2024 | 138.60M | 1.61% |
Feb 28, 2024 | 136.40M | -3.19% |
Feb 27, 2024 | 140.90M | 1.08% |
Feb 26, 2024 | 139.40M | 2.73% |
Feb 23, 2024 | 135.70M | -2.09% |
Feb 22, 2024 | 138.60M | 2.14% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NGM Biopharmaceuticals | 129.37M |
Sangamo Therapeutics | 127.23M |
Genetron Holdings | 127.13M |
Seer, Inc. | 125.34M |
Kinnate Biopharma | 125.23M |
Zentek | 123.00M |
VistaGen Therapeutics | 122.42M |
PDS Biotechnology | 119.77M |